Benjamin August is a member of the Global Business Development & Licensing team at Daiichi Sankyo, where he is focused on external innovation. His academic background is a PhD in Cell Biology with focus on immunology, followed by post-doctoral training in hematology and oncology. He has held Medical Affairs and Business Development roles in biotech and pharmaceutical companies for the last 17 years. Benjamin received his executive MBA from Mannheim Business School and ESSEC. He is currently looking for early stage research across therapy areas and technology platforms that show promise in finding next generation therapeutics.